Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease

Oxidation-Specific Epitopes Are Danger-Associated Molecular Patterns Recognized by Pattern Recognition Receptors of Innate Immunity

(2011) Yury I. Miller et al.   CIRCULATION RESEARCH

Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study

(2011) Amir Ravandi et al.   JOURNAL OF LIPID RESEARCH

Human Oxidation-Specific Antibodies Reduce Foam Cell Formation and Atherosclerosis Progression

(2011) Sotirios Tsimikas et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Malondialdehyde–acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis

(2010) Michael J. Duryee et al.   FREE RADICAL BIOLOGY AND MEDICINE

Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet

(2010) Nastaran Faghihnia et al.   JOURNAL OF LIPID RESEARCH

Clinical significance of the humoral immune response to modified LDL

(2009) Maria F. Lopes-Virella et al.   CLINICAL IMMUNOLOGY

Experimental immunotherapeutic approaches for atherosclerosis

(2009) Shahzada Amir et al.   CLINICAL IMMUNOLOGY

Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans

(2009) Meng-Yun Chou et al.   JOURNAL OF CLINICAL INVESTIGATION